| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SWAV | Common Stock | Options Exercise | $34.2K | +10K | +7.09% | $3.42* | 151K | Jan 16, 2024 | Direct | F1 |
| transaction | SWAV | Common Stock | Sale | -$64.7K | -300 | -0.2% | $215.54 | 151K | Jan 16, 2024 | Direct | F1, F2 |
| transaction | SWAV | Common Stock | Sale | -$1.33M | -6.15K | -4.08% | $216.87 | 145K | Jan 16, 2024 | Direct | F1, F3 |
| transaction | SWAV | Common Stock | Sale | -$284K | -1.3K | -0.9% | $217.97 | 143K | Jan 16, 2024 | Direct | F1, F4 |
| transaction | SWAV | Common Stock | Sale | -$274K | -1.25K | -0.87% | $219.27 | 142K | Jan 16, 2024 | Direct | F1, F5 |
| transaction | SWAV | Common Stock | Sale | -$220K | -1K | -0.7% | $220.00 | 141K | Jan 16, 2024 | Direct | F1, F6 |
| transaction | SWAV | Common Stock | Award | $0 | +22.1K | +15.65% | $0.00 | 163K | Jan 17, 2024 | Direct | F7 |
| transaction | SWAV | Common Stock | Tax liability | -$2.23M | -10.3K | -6.28% | $217.78 | 153K | Jan 18, 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SWAV | Stock Option | Options Exercise | $0 | -10K | -3.18% | $0.00 | 305K | Jan 16, 2024 | Common Stock | 10K | $3.42 | Direct | F1, F8 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023. |
| F2 | The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $215.23 to $216.18. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. |
| F3 | The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $216.47 to $217.41. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. |
| F4 | The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $217.49 to $218.43. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. |
| F5 | The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $218.70 to $219.58. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. |
| F6 | The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $219.79 to $220.29. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. |
| F7 | Represents the vesting and settlement of a performance-based restricted stock unit award granted on February 1, 2022, resulting from the achievement of certain performance criteria related to the compound annual growth rate of the Issuers revenue during the measurement period January 1, 2022 through December 31, 2023. |
| F8 | Fully vested. |